|
Executive management nominationsThe Board of Directors of Hermo Pharma Ltd. nominated today Mr. Juhani Lahdenperä as the new Chief Executive Officer (CEO) effective on February 1, 2010. Dr. Henri J. Huttunen, previously CEO of Hermo Pharma Ltd., will start as Chief Scientific Officer (CSO) also effective on February 1, 2010. Read more on company's executive management 15.12.2009 |
